The circulating concentration and ratio of total and high molecular weight adiponectin in post-menopausal women with and without osteoporosis and its association with body mass index and biochemical markers of bone metabolism

Clinical Biochemistry

Volumn 42, Issue 13-14, 2009, Pages 1375-1380

  Sodi, R ^a,b   Hazell, M J ^c   Durham, B H ^a,b   Rees, C ^a,b   Ranganath, L R ^a,b   Fraser, W D ^a,b  

^a Faculty of Medicine   (United Kingdom)

^b ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c OXFORD BROOKES UNIVERSITY   (United Kingdom)

Author keywords

Adiponectin; Body mass index; Bone biomarkers; Bone mineral density; Osteoporosis; Osteoprotegerin

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; OSTEOPROTEGERIN; PROCOLLAGEN TYPE 1 AMINOPROPEPTIDE; PROTEIN PRECURSOR; UNCLASSIFIED DRUG;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BIOCHEMISTRY; BODY MASS; BONE DENSITY; BONE METABOLISM; CIGARETTE SMOKING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR WEIGHT; OBESITY; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN SYNTHESIS;

ADIPONECTIN; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BODY MASS INDEX; BONE AND BONES; BONE DENSITY; COLLAGEN TYPE I; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR WEIGHT; OSTEOPOROSIS, POSTMENOPAUSAL; OSTEOPROTEGERIN; PEPTIDE FRAGMENTS; PEPTIDES; POSTMENOPAUSE; PROCOLLAGEN;

EID: 69249213476     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.06.003     Document Type: Article

References (32)

1. Maeda K., Okubo K., Shimomura I., Funahashi T., and Matsuzawa Y. Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adiPose Most abundant Gene transcript 1). Biochem. Biophys. Res. Commun. 221 (1996) 286-289
2. Hu E., Liang P., and Spiegelman B.M. AdipoQ is a novel adipose-specific gene dyregulated in obesity. J. Biol. Chem. 271 (1996) 286-289
3. Haluzik M., Parizkova J., and Haluzik M.M. Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol. Rev. 53 (2004) 123-129
4. Shimada K., Miyazaki T., and Daida H. Adiponectin and atherosclerotic disease. Clin. Chim. Acta. 344 (2004) 1-12
5. Hug C., and Lodish H.F. The role of the adipocyte hormone adiponectin in cardiovascular disease. Curr. Opin. Pharmacol. 5 (2005) 129-134
6. Yatagai T., Nagasaka S., Taniguchi A., et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 52 (2003) 1274-1278
7. Lindsay R.S., Funahashi T., Hanson R.L., et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360 (2002) 57-58
8. Kanazawa I., Yamaguchi T., Yamamoto M., Yamauchi M., Yano S., and Sugimoto T. Relationship between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus. Eur. J. Endocrinol. 160 (2009) 265-273
9. Peng X.-D., Xie H., Zhao Q., Wu X.-P., Sun Z.-Q., and Liao E.-Y. Relationship between adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Clin. Chem. Acta 387 (2008) 31-35
10. Richards J.B., Valdes A.M., Burling K., Perks U.C., and Spector T.D. Serum adiponectin and bone mineral density in women. J. Clin. Endocrinol. Metab. 92 (2007) 1517-1523
11. Jurimae J., Rembel K., Jurimae T., and Rehand M. Adiponectin is associated with bone mineral density in perimenopausal women. Horm. Metab. Res. 37 (2005) 297-302
12. Lenchik L., Register T.C., Hsu F.C., et al. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 33 (2003) 646-651
13. Kontogianni M., Dafni U.G., Routsias J., and Skopouli F.N. Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. J. Bone Miner. Res. 19 (2004) 546-551
14. Huang K.C., Cheng W.C., Yen R.F., Tsai K.S., Tai T.Y., and Yang W.S. Lack of independent relationship between plasma adiponectin, leptin levels and bone density in nondiabetic female adolescents. Clin. Endocrinol. 61 (2004) 204-208
15. Jurimae J., and Jurimae T. Plasma adiponectin concentration in healthy pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables. Am. J. Physiol. Endocrinol. Metab. 293 (2007) E42-E47
16. Oh K.W., Lee W.Y., Rhee E.J., et al. The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin. Endocrinol. 63 (2005) 131-138
17. Lee N.K., Sowa H., Hinoi E., et al. Endocrine regulation of energy metabolism by the skeleton. Cell 130 (2007) 456-469
18. Ducy P., Amling M., Takeda S., et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100 (2000) 197-207
19. Berner H.S., Lyngstadaas S.P., Spahr A., et al. Adiponectin and its receptors are expressed in bone-forming cells. Bone 35 (2004) 842-849
20. Luo X.H., Guo L.J., Xie H., et al. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signalling pathway. J. Bone Miner. Res. 21 (2006) 1648-1656
21. Lee W.Y., Rhee E.J., Oh K.W., et al. Identification of adiponectin and its receptors in human osteoblast-like cells and association of T45G polymorphism in exon 2 of adiponectin gene with lumbar spine bone mineral density in Korean women. Clin. Endocrinol. 65 (2006) 631-637
22. Luo X.H., Guo L.J., Yuan L.Q., et al. Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signalling pathway. Exp. Cell Res. 309 (2005) 99-109
23. Pajvani U.B., Du X., Combs T.P., et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. J. Biol. Chem. 278 (2003) 9073-9085
24. Pajvani U.B., Hawkins M., Combs T.P., et al. Complex distribution, not absolute amount of adiponectin, correlates with Thiazolidinedione-mediated improvement in insulin sensitivity. J. Biol. Chem. 279 (2004) 12152-12162
25. Baines M., Kredan M.B., Usher J., et al. The association of homocysteine and its determinants MTHFR genotype, folate, vitamin B12 and vitamin B6 with bone mineral density in postmenopausal British women. Bone 40 (2007) 730-736
26. Adams K.F., Schatzkin A., Harris T.B., et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N. Engl. J. Med. 355 (2006) 763-778
27. von Eynatten M., Hamann A., Teardella D., Nawroth P.P., Brenner H., and Rothenbacher D. Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease. Clin. Chem. 52 (2006) 853-859
28. Barber T.M., Hazell M., Christodoulides C., et al. Serum levels of retinol-binding protein 4 and adiponectin in women with polycystic ovary syndrome: an association with visceral fat but no evidence for fat mass-independent effects on pathogenesis in this condition. J. Clin. Endocrinol. Metab. 93 (2008) 2859-2865
29. Ebinuma H., Miyazaki O., Yago H., Hara K., Yamauchi T., and Kadowaki T. A novel ELISA system for selective measurement of human adiponectin multimers by using proteases. Clin. Chim. Acta 372 (2006) 47-53
30. Khosla S., Atkinson E.J., Riggs B.L., and Melton L.J. Relationship between body composition and bone mass in women. J. Bone Miner. Res. 11 (1996) 857-863
31. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology 142 (2001) 5050-5055
32. Shinoda Y., Yamaguchi M., Ogata N., et al. Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J. Cell. Biochem. 99 (2006) 196-208